Systemic lupus erythematosus (SLE), which is the most common form Cutaneous lupus, which is limited to the skin Drug-induced lupus, which is a lupus-like disease caused by certain prescription drugs Neonatal lupus, which is a rare condition that impacts infants in women who have lupus Is ther...
Lupus is an autoimmune disease in which the immune system mistakenly attacks healthy organs and tissues. There are four types of lupus, but the most common is systemic lupus erythematosus (SLE), affecting 70% of all people living with the disease.It’s a chronic condition characterized by the ...
What is systemic lupus erythematosus (SLE)?.SLE's an autoimmune disease that can affect any tissue or organ in the body, but most often affects the skin, kidneys, and joints. SLE is a chronic multi-system disorder that most commonly affects women during their reproductive years. The ...
其中,德国柏林夏里特医院Kronke G研究团队的个案报道[23]揭示了“BCMA+CD3双特异性抗体”在治疗难治性系统性红斑狼疮(SLE)中的显著疗效。该23岁女性患者具有6年难治性SLE病史,临床表现为活动性狼疮性肾炎、溶贫、多形性皮疹和多关节炎。经过双抗...
Belimumab infusion is used to treat active systemic lupus erythematosus (SLE) and active lupus ... Reviews & ratings 7.9 / 10 66 Reviews View more How can I manage my symptoms? Rest when you feel it is needed.Slowly start to do more each day. Return to your daily activities as directed...
Lupus is a lifelong disease that affects all parts of your body. Lupus has active and quiet periods. The active periods, also called flares, are when you have symptoms. The quiet periods, or remission, are when you have few or no symptoms. A remission period may last months or years, ...
Systemic lupus is an autoimmune disease affecting many parts of the body such as the joints, skin, kidneys, heart, lungs, blood vessels, and brain.
Systemic lupus erythematosusanti-DNA antibodynucleosomeautoreactive T cellThe mechanism by which anti-DNA antibodies cause glomerulonephritis in systemic lupus erythematosus (SLE) has not been fully elucidated. However, not a few recent studies suggest the pivotal role of nucleosomal histones in the ...
Autoimmune diseases are highly diverse and the level of patient heterogeneity observed makes the development of effective treatments challenging. In addition, these diseases also have overlapping symptoms, making diagnosis difficult. For example, Oncimmune’s research into Systemic Lupus Erythematosus (SLE)...
In SLE therapeutics new analyses of the two phase III clinical trials with belimumab provided some guidance for clinicians as to which patients have the highest likelihood to benefit from this biologic. A large randomized trial of abatacept for lupus nephritis was reported as negative, but a post...